Oncotype DX testing and differences in use of chemotherapy by age in an integrated system

被引：0
|
作者：
Aller, Ashley
Lyon, Liisa
Habel, Laurel
Shirazi, Aida
Liu, Raymond
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3822
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3822
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Use of Oncotype DX in Bilateral Breast Cancer
    Li, Pamela
    Cate, Sarah
    Malamud, Stephen
    Chadha, Manjeet
    Gillego, Alyssa
    Boolbol, Susan
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 74 - 75
  • [22] Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?
    Conlon, Niamh
    Ross, Dara S.
    Howard, Jane
    Catalano, Jeffrey P.
    Dickler, Maura N.
    Tan, Lee K.
    BREAST JOURNAL, 2015, 21 (05) : 514 - 519
  • [23] Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
    Megan C. Roberts
    Morris Weinberger
    Stacie B. Dusetzina
    Michaela A. Dinan
    Katherine E. Reeder-Hayes
    Melissa A. Troester
    Lisa A. Carey
    Stephanie B. Wheeler
    Breast Cancer Research and Treatment, 2015, 153 : 191 - 200
  • [24] Oncotype DX® recurrence score as a predictor of response to neoadjuvant chemotherapy
    Riba, Luis
    Gruner, Ryan
    Tung, Nadine
    James, Ted
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 264 - 264
  • [25] Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
    Roberts, Megan C.
    Weinberger, Morris
    Dusetzina, Stacie B.
    Dinan, Michaela A.
    Reeder-Hayes, Katherine E.
    Troester, Melissa A.
    Carey, Lisa A.
    Wheeler, Stephanie B.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (01) : 191 - 200
  • [26] The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre
    McVeigh, Terri Patricia
    Hughes, Lauren M.
    Miller, Nicola
    Sheehan, Margaret
    Keane, Maccon
    Sweeney, Karl J.
    Kerin, Michael J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (16) : 2763 - 2770
  • [27] The Impact of Oncotype DX on Adjuvant Chemotherapy for Invasive Lobular Carcinoma
    Deneve, J. L.
    Lee, M. C.
    Joh, J. E.
    Acs, G.
    Khakpour, N.
    Soliman, H.
    Laronga, C.
    Kiluk, J. V.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S76 - S76
  • [28] Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy
    Alison M. Pease
    Luis A. Riba
    Ryan A. Gruner
    Nadine M. Tung
    Ted A. James
    Annals of Surgical Oncology, 2019, 26 : 366 - 371
  • [29] Patient-Centered Communication for Discussing Oncotype DX Testing
    Roberts, Megan C.
    Bryson, Amy
    Weinberger, Morris
    Dusetzina, Stacie B.
    Dinan, Michaela A.
    Reeder-Hayes, Katherine E.
    Wheeler, Stephanie B.
    CANCER INVESTIGATION, 2016, 34 (05) : 205 - 212
  • [30] Oncotype DX testing in early-stage node-positive breast cancer and impact on chemotherapy use at a comprehensive cancer center.
    Losk, Katya
    Freedman, Rachel A.
    Mittendorf, Elizabeth A.
    Tan-Wasielewski, Zhenying
    Trippa, Lorenzo
    King, Tari A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345